|
FDA approves first gene therapy for treatment of aromatic L-amino acid decarboxylase deficiency
|
14 November 2024 |
|
FDA approves new treatment for hemophilia A or B
|
11 October 2024 |
|
FDA approves nasal spray influenza vaccine for self- or caregiver-administration
|
20 September 2024 |
|
FDA approves first nasal spray for treatment of anaphylaxis
|
15 August 2024 |
|
FDA approves nonsteroidal treatment for Duchenne muscular dystrophy
|
25 March 2024 |
|
FDA approves first gene therapies to treat patients with sickle cell disease
|
08 December 2023 |
|
FDA approves first therapy for rare type of non-cancerous tumors
|
28 November 2023 |
|
FDA approves first treatment for patients with rare inherited blood clotting disorder
|
09 November 2023 |
|
FDA takes action on updated mRNA COVID-19 vaccines to better protect against currently circulating variants
|
11 September 2023 |
|
FDA approves first oral treatment for postpartum depression
|
07 August 2023 |
|
FDA approves first nonprescription daily oral contraceptive
|
13 July 2023 |
|
FDA approves first gene therapy for treatment of certain patients with Duchenne muscular dystrophy
|
22 June 2023 |
|
FDA announces additional steps to modernize clinical trials
|
06 June 2023 |
|
FDA approves first drug to treat agitation symptoms associated with dementia due to Alzheimer's disease
|
11 May 2023 |
|
FDA approves first respiratory syncytial virus (RSV) vaccine
|
04 May 2023 |
|
FDA approves cell therapy for patients with blood cancers to reduce risk of infection following stem cell transplantation
|
17 April 2023 |
|
FDA approves first over-the-counter naloxone nasal spray
|
29 March 2023 |
|
FDA grants Accelerated Approval for Alzheimer's disease treatment
|
06 January 2023 |
|
FDA approves new HIV drug for adults with limited treatment options
|
22 December 2022 |
|
FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
|
16 December 2022 |